AQUAHeart® Inc. is part of a group of U.S.-based medical device companies that share a common international patent structure / broad IP portfolio as well as a fundamentally common technology platform consisting of a generator and vapor management system. Founded by serial entrepreneur, former Majo Clinic Professor and practicing doctor Dr. Virender K Sharma and supported by an experienced management team of industry experts and an international scientific advisory board, AQUAHeart® has developed a groundbreaking, disruptive cardiac ablation catheter application for the treatment of atrial fibrillation. The company plans for first in Human clinical trials in 2023